Open access

ICare-FASTER (Improving Care by Faster Risk Stratification Through Use of High-Sensitivity Point-of-Care Troponin in Patients Presenting With Possible Acute Coronary Syndrome in the Emergency Department): A Stepped-Wedge Cluster-Randomized Trial.

Martin P. Than J. Pickering Laura R. Joyce V. Buchan C. M. Florkowski N. L. Mills Laura M. Hamill J. Prystowsky S. Harger Mary E. Reed Jared Bayless A. Feberwee T. Attenburrow Timothy Norman Oliver Welfare Tamika Heiden P. Kavsak A. Jaffe F. Apple W. F. Peacock Louise Cullen S. Aldous A. M. Richards Cameron Lacey R. Troughton Christopher M. A. Frampton R. Body Christian Mueller S. Lord Peter M. George G. Devlin

Oct 2026 · Circulation · 0 citations · 32 references

Medicine

Abstract

Background

Point-of-care high-sensitivity cTn (cardiac troponin; hs-cTn) testing has the potential to expedite decision-making and reduce emergency department (ED) length of stay for patients presenting with possible myocardial infarction by ensuring that results are consistently available when sought by clinicians. We assessed the real-life effectiveness and safety of implementing point-of-care hs-cTn testing in the ED.

Methods

We conducted a pragmatic, stepped-wedge cluster-randomized trial. The control arm was usual care with an accelerated diagnostic pathway using a single-sample rule-out step with a central laboratory hs-cTn assay. The intervention arm used the same pathway with a point-of-care hs-cTnI assay. The primary effectiveness outcome was ED length of stay assessed using a generalized linear mixed model. The safety outcome was myocardial infarction or cardiac death within 30 days.

Results

Six sites participated, with 59 980 ED presentations (44 747 individuals; mean 61±19 years of age; 49.5% female) from February 2023 through January 2025; 31 392 presentations were during the intervention arm. After adjustment for covariates associated with length of stay, the intervention reduced length of stay by 13% (95% CI, 9%-16%; P<0.001), corresponding to a reduction of 47 minutes (95% CI, 33-61 minutes) from a mean length of stay in the control arm of 376 minutes. The 30-day myocardial infarction or cardiac death rate was similar in the control and intervention arms (0.39% and 0.39%, respectively; P=0.54).

Conclusions

Implementation of whole-blood hs-cTnI testing at the point of care into an accelerated diagnostic pathway was safe and reduced length of stay in the ED compared with laboratory testing. REGISTRATION URL: https://www.anzctr.org.au; Unique identifier: ACTRN12619001189112.

DOI PubMed Semantic Scholar

Read PDF